Exelixis (NASDAQ:EXEL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday. Other equities analysts have also issued reports about the company. Royal Bank of Canada upped their target price on Exelixis from $26.00 to $28.00 and gave the […]